Publications

- International refereed journals 

2020

Delatycki MB, Alkuraya F, Archibald A, Castellani C, Cornel M, Grody WW, Henneman L, Ioannides AS, Kirk E, Laing N, Lucassen A, Massie J, Schuurmans J, Thong MK, van Langen I, Zlotogora J. International perspectives on the implementation of reproductive carrier screening. Prenat Diagn. 2019. doi: 10.1002/pd.5611.

2019

van der Meij KRM, Sistermans EA, Macville MVE, Stevens SJC, Bax CJ, Bekker MN, Bilardo CM, Boon EMJ, Boter M, Diderich KEM, de Die-Smulders CEM, Duin LK, Faas BHW, Feenstra I, Haak MC, Hoffer MJV, den Hollander NS, Hollink IHIM, Jehee FS, Knapen MFCM, Kooper AJA, van Langen IM, Lichtenbelt KD, Linskens IH, van Maarle MC, Oepkes D, Pieters MJ, Schuring-Blom GH, Sikkel E, Sikkema-Raddatz B, Smeets DFCM, Srebniak MI, Suijkerbuijk RF, Tan-Sindhunata GM, van der Ven AJEM, van Zelderen-Bhola SL, Henneman L, Galjaard RH, Van Opstal D, Weiss MM; Dutch NIPT Consortium. TRIDENT-2: National implementation of genome-wide non-Invasive prenatal testing as a first-tier screening test in the Netherlands. Am J Hum Genet 2019;105:1091-1101. 

Blom M, Schoenaker MHD, Hulst M, de Vries MC, Weemaes CMR, Willemsen MAAP, Henneman L, van der Burg M. Dilemma of reporting incidental findings in newborn screening programs for SCID: parents’ perspective on ataxia telangiectasia. Front Immunol. 2019;10:2438.

Vollgraff Heidweiller-Schreurs CA, de Boer MA, van der Meij KRM, Bax CJ, de Groot CJM, Henneman L. Women’s experiences of monitoring the small-for-gestational age fetus by ultrasound: a qualitative study. Plos One, 2019;14:e0216052.

van den Heuvel LM, Huisinga MJ, Hoedemaekers YM, Baas AF, Plantinga M, Henneman L, van Tintelen JP, Smets EMA, Christiaans I. Informing relatives at risk of inherited cardiac conditions: experiences and attitudes of healthcare professionals and counselees. Eur J Hum Genet 2019;27:1341-1350.

Nijmeijer SCM, Conijn T, Lakeman P, Henneman L, Wijburg FA, Haverman L. Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolism.  Mol Genet Metab. 2019;126:14-22.

Holtkamp KCA, Henneman L, Gille JJP, Meijers-Heijboer E.J, Cornel MC, Lakeman P. Direct-to-consumer carrier screening for cystic fibrosis via a hospital website: a six-year evaluation. J Comm Genet 2019;10:249-257

Jackson L, O'Connor A, Paneque M, Curtisova V, Lunt PW, Pourova RK, Macek M Jr, Stefansdottir V, Turchetti D, Campos M, Henneman L, Godino L, Skirton H, Cornel MC. The Gen-Equip Project - evaluation and impact of genetics e-learning resources for primary care in six European languages. Genet Med. 2019;21:718-726.

2018

Van Bruggen MJ, Henneman L, Timmermans DRM. Women’s decision making regarding prenatal screening for fetal aneuploidy: A qualitative comparison between 2003 and 2016. Midwifery 2018;64:93-100.

Mathijssen IB, Holtkamp KCA, Ottenheim CPE, Van Eeten Nijman JMC, Lakeman P, Ottenhof W, Meijers-Heijboer H, Van Maarle MC, Henneman L. Preconception carrier screening for multiple diseases: Evaluation of a screening offer in a Dutch founder population. Eur J Hum Genet 2018;26: 166-175.

Beunders G, Dekker M, Haver O, Meijers-Heijboer HJ, Henneman L. Recontacting in light of new genetic diagnostic techniques for patients with intellectual disability: Feasibility and parental perspectives. Eur J Med Genet 2018;61:213-218.

Van Opstal D, van Maarle MC, Lichtenbelt K, Weiss MM, Schuring-Blom H, Bhola SL, Hoffer MJV, Huijsdens-van Amsterdam K, Macville MV, Kooper AJA, Faas BHW,  Govaerts L, Tan-Sindhunata GM, den Hollander N, Feenstra I, Galjaard RJH, Oepkes D, Ghesquiere S, Brouwer RWW, Beulen L, Bollen S, Elferink MG,  Straver R, Henneman L, Page-Christiaens GC, Sistermans EA, for the Dutch NIPT Consortium. Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPT: results of the TRIDENT study. Genet Med. 2018 20;480-485.  

Martin L, Gitsels-van der Wal JT, de Boer MA, Vanstone M , Henneman L. Introduction of non-invasive prenatal testing as a first-tier aneuploidy screening test: A survey among Dutch midwives about their role as counsellors. Midwifery 2018;56:1-8.

Holtkamp KCA, Lakeman P, Hader H, Jans SMJP, Hoenderdos M, Playfair HAM, Cornel MC, Peters M, Henneman L. Experiences of a high-risk population with prenatal hemoglobinopathy carrier screening in a primary care setting: A qualitative study. J Genet Couns 2018;27:635–646.

2017

van Schendel RV, van El CG, Pajkrt E, Henneman L, Cornel MC. Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutions. BMC Health Serv Res 2017;17:670.

Van Schendel RV, Page-Christiaens L, Beulen L, Bilardo CM, de Boer MA, Coumans AB, Faas BH, van Langen IM, Lichtenbelt KD, van Maarle MC, Macville MV, Oepkes D, Pajkrt E, Henneman L for the Dutch NIPT Consortium. Women’s experience with NIPT and emotional wellbeing and satisfaction after test results. J Genet Couns. 2017;26:1348-1356

Mathijssen IB, van Maarle MC, Kleiss IIM, Redeker EJW, ten Kate LP, Henneman L, Meijers-Heijboer H. With expanded carrier screening, founder populations run the risk of being overlooked. J Comm Genet 2017;8:327–333.

Tamminga S, van Dussen L, Verweij EJ, de Boer MA, Cornel MC, Henneman L, for the Dutch NIPT Consortium. What do people want to know about NIPT? Content analysis of questions emailed to national NIPT information websites. Prenat Diagn 2017; 37: 412-415

Holtkamp KCA, Vos EM, Rigter T, Lakeman P, Henneman L, Cornel MC. Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape. BMC Health Services Research 2017; 17:146

Van Schendel RV, Kater-Kuipers A, van Vliet-Lachotzki EH, Dondorp WJ, Cornel MC, Henneman L. What do parents of children with Down syndrome think about non-invasive prenatal testing (NIPT)? J Genet Couns 2017; 26: 522-531.

Holtkamp KCA, Mathijssen IB, Lakeman P, Van Maarle M, Dondorp WJ, Henneman L, Cornel MC. Factors for successful implementation of population-based expanded carrier screening: Learning from existing initiatives. Eur J Publ Health 2017;27:372-377

Dommering CJ, Henneman L, van der Hout AH, Jonker MA, Tops CM, van den Ouweland AM, van der Luijt RB, Mensenkamp AR, Hogervorst FB, Redeker EJ, de Die-Smulders CE, Moll AC, Meijers-Heijboer H. Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands. Familial Cancer 2017; 16: 271-277.

2016

Oepkes D, Page-Christiaens LC, Bax CJ, Bekker MN, Bilardo CM, Boon EM, Schuring-Blom GH, Coumans AB, Faas BH, Galjaard RH, Go AT, Henneman L, Macville MV, Pajkrt E, Suijkerbuijk RF, Huijsdens-vanAmsterdam K, Van Opstal D, Verweij EJ, Weiss MM, Sistermans EA for the Dutch NIPT Consortium. Trial by Dutch Laboratories for Evaluation of Non-Invasive Prenatal Testing. Part I - Clinical Impact.  Prenat Diagn 2016;36:1083-1090

Van Schendel RV, Page-Christiaens L, Beulen L, Bilardo CM, de Boer MA, Coumans AB, Faas BH, van Langen IM, Lichtenbelt KD, van Maarle MC, Macville MV, Oepkes D, Pajkrt E, Henneman L for the Dutch NIPT Consortium.  Trial by Dutch Laboratories for Evaluation of Non-Invasive Prenatal Testing. Part II - Women's Perspectives. Prenat Diagn 2016;36:1091-1098.

Van der Hout S, Holtkamp K, Henneman L, de Wert G, Dondorp WJ. Advantages of expanded universal carrier screening: What is at stake? Eur J Hum Genet 2016;25:17-21.

Van Driel CMG, Oosterwijk JC, Meijers-Heijboer EJ, van Asperen CJ, Zeijlmans IA, de Vries J, Mourits MJE, Henneman L, Timmermans DRM, de Bock GH. Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees. Breast;30:66-72.

Perdok H, Jans S, Verhoeven C, Henneman L, Wiegers TA, Mol BW, Schellevis FG, de Jonge A. Opinions of maternity care professionals and other stakeholders about integration of maternity care: a qualitative study in the Netherlands. BMC Pregnancy Childbirth 2016;16:188.

Tamminga S, van Maarle M, Henneman L, Oudejans CB, Cornel MC, Sistermans EA. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing. Adv Clin Chem 2016;74:63-102.

Crombag N, van Schendel RV, Schielen PC, Bensing JM, Henneman L. Present to future: what the reasons for declining first-trimester combined testing tell us about accepting or declining cell-free DNA testing. Prenat Diagn 2016;36:587-90

Henneman L, Borry P, Chokoshvili D, Cornel MC, van El CG, Forzano F, Hall A, Howard HC, Janssens S, Kayserili H, Lakeman P, Lucassen A, Metcalfe SA, Vidmar L, de Wert G, Dondorp WJ, Peterlin B, on behalf of the European Society of Human Genetics. Responsible implementation of expanded carrier screening. Eur J Hum Genet 2016;24:e1-e12.

Hill M, Johnson JA, Langlois S, Lee H, Winsor S, Dineley B, Horniachek M, Lalatta F, Ronzoni L, Barrett AN, Advani HA, Choolani M, Rabinowitz R, Pajkrt E, Van Schendel RV, Henneman L, Rommers W, Bilardo CM, Rendeiro P, Ribeiro MJ, Rocha J, Bay Lund IC, Petersen OB, Becher N, Vogel I, Stefánsdottir V, Olafsdottir S,  Gottfredsdottir H, Morris S, Chitty LS. Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals. Eur J Hum Genet 2016;24:968-75

Van Teeffelen SR, Douglas CMW, Van El CG, Weinreich SS, Henneman L, Radstake M, Cornel MC. Mothers’ views on longer storage of dried blood spots for research, forensics and healthcare: an online survey. Publ Health Genomics 2016:19:25-33.

Henneman L, Page-Christiaens GC, Oepkes D. [Non-invasive prenatal testing: challenges for future implementation]. Ned Tijdschr Geneeskd. 2015;159:A9479. Dutch]

Janssens S, Chokoshvili D, Binst C, Mahieu I, Henneman L, De Paepe A, Borry P. Attitudes of cystic fibrosis patients and parents towards carrier screening and related reproductive issues. Eur J Hum Genet 2016;24:506-12. 

Wijdenes M, Henneman L, Dondorp WJ, Cornel MC, Timmermans DR. Users evaluate a detailed familial risk questionnaire as valuable and no more time consuming than a simple enquiry in a web-based diabetes risk assessment tool. Public Health 2016;130:87-90.

Holtkamp KCA, Van Maarle MC, Schouten M, Dondorp WJ, Lakeman P, Henneman L. Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?  Eur J Hum Genet. 2016;24:171-7

2015

Tamminga S, van Schendel RV, Rommers W, Bilardo CM, Pajkrt E, Dondorp WJ, van Maarle M, Cornel MC, Henneman L. Changing to NIPT as a first-tier screening test and future perspectives: Opinions of health professionals. Prenatal Diagnosis 2015;35:1316-2

Dondorp W, De Wert G, Bombard Y, Bianchi DW, Bergmann C, Borry P, Chitty LS, Fellmann F, Forzano F, Hall A, Henneman L, Howard HC, Lucassen A, Ormond K, et al, on behalf of the European Society of Human Genetics (ESHG) and the American Society of Human Genetics (ASHG). Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet 2015;23:1438-1450.

Henneman L, McBride CM, Cornel MC, Duquette D, Qureshi N. Screening for familial hypercholesterolemia in children: what can we learn from adult screening programs? Healthcare 2015;3:1018-1030.

Kelmemi W, Teeuw ME, Bochdanovits Z, Ouburg S, Jonker MA, Alkuraya F, Hashem M, Kayserili H, van Haeringen A, Sheridan E, Masri A, Cobben JM, Rizzu P, Kostense PJ, Dommering CJ, Henneman L, Bouhamed-Chaabouni H, Heutink P, Ten Kate LP, Cornel MC. Determining the genome-wide kinship coefficient seems unhelpful in distinguishing consanguineous couples with a high versus low risk for adverse reproductive outcome. BMC Med Genet. 2015;16:50.

Janssens S, Kalokairinou L, Chokoshvili D, Binst C, Mahieu I, Henneman L, De Paepe A, Borry P. Attitudes of cystic fibrosis patients and their parents towards direct-to-consumer genetic testing for carrier status. Pers Med 2015;12: 99–107.

Houwink EJ, Muijtjens AM, van Teeffelen SR, Henneman L, Rethans JJ, Jacobi F, van der Jagt L, Stirbu I, van Luijk SJ, Stumpel CT, Meijers-Heijboer HE, van der Vleuten C, Cornel MC, Dinant GJ. Effect of comprehensive oncogenetics training interventions for general practitioners, evaluated at multiple performance levels. PLoS One. 2015 2;10:e0122648.

Chowdhury S, Henneman L, Dent T, Hall A, Burton A, Pharoah P, Pashayan N, Burton H. Do health professionals need additional competencies for stratified cancer prevention based on genetic risk profiling? J Pers Med 2015;5:191-212.

Bosma AR, Rigter T, Weinreich SS, Cornel MC, Henneman L. A genetic diagnosis of maturity-onset diabetes of the young (MODY): Experiences of patients and family members. Diabet Med 2015;32:1385-92.

Van Schendel RV, Dondorp WJ, Timmermans DRM, van Hugte EJ, de Boer A, Pajkrt E, Lachmeijer AMA, Henneman L. NIPT-based screening for Down syndrome and beyond: what do pregnant women think? Prenatal Diagnosis 2015;35:598-604.

Mathijssen IB, Henneman L, Van Eeten-Nijman JMC, Lakeman P, Ottenheim CPE, Redeker EJW, Ottenhof W, Meijers-Heijboer H, Van Maarle MC. Targeted carrier screening for four recessive disorders: High detection rate within a founder population. Eur J Med Genet 2015;58:123-128. 

Van der Zwaag AM, Weinreich SS, Bosma AR, Rigter T, Losekoot M, Henneman L, Cornel MC. Current and best practices of genetic testing for Maturity Onset Diabetes of the Young (MODY): Views of professional experts. Publ Health Genomics 2015;18:52-59.

Weinreich SS, Bosma AR, Henneman L, Rigter T, Spruijt C, Grimbergen A, Breuning M, De Koning E, Losekoot M, Cornel MC. A decade of molecular genetic testing for MODY: retrospective study of utilisation in the Netherlands. Eur J Hum Genet 2015;23:213-33

2014

Teeuw ME, Waisfisz Q, Zwijnenburg PJG, Sistermans EA, Weiss M,  Henneman L, Ten Kate LP, Cornel MC, Meijers-Heijboer EJ. First steps in exploring prospective exome sequencing of consanguineous couples. European Journal of Medical Genetics 2014;57:613-6.Ten Kate LP,

Teeuw ME, Henneman L. Cornel MC. Consanguinity and Endogamy in the Netherlands: Demographic and Medical Genetic Aspects. Human Heredity 2014;77:161-166.

Rigter T, Henneman L, Broerse JEW, Shepherd M, Blanco I, Kristoffersson U, Cornel MC. Developing a framework for implementation of genetic services: learning from examples of testing for monogenic forms of common diseases. Journal of Community Genetics 2014;5:337-47

Van Schendel RV, Kleinveld JH, Dondorp WJ, Pajkrt E, Timmermans DRM, Holtkamp KCA, Karsten M, Vlietstra AL, Lachmeijer AMA, Henneman L. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet 2014;22:1345-50.

Rigter T, Van Aart C, Elting M, Cornel MC, Henneman L. Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients. Clin Genet. 2014;85:417-22.

Houwink EJF, Muijtjens AMM, Van Teeffelen SR, Henneman L, Rethans JJ, Van der Jagt L, Van Luijk SJ, Dinant GJ, Van der Vleuten C, Cornel MC. Effectiveness of oncogenetics training on general practitioners’ consultation skills: a randomized controlled trial. Genetics in Medicine 2014;16:45-52.

Ten Kate LP, Teeuw M, Henneman L, Cornel MC. Comment on Gialluisi et al. Eur J Hum Genet 2014; 22:157.

Vermeulen E, Henneman L, van El CG, Cornel MC. Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: a survey study. Eur J Public Health 2014; 24:768-75.

Houwink EJ, van Teeffelen SR, Muijtjens AM, Henneman L, Jacobi F, van Luijk SJ, Jan Dinant G, van der Vleuten C, Cornel MC. Sustained effects of online genetics education: a randomized controlled trial on oncogenetics. Eur J Hum Genet 2014; 22:310-6.

Teeuw ME, Loukili G, Bartels EA, Ten Kate LP, Cornel MC, Henneman L. Consanguineous marriage and reproductive risk: attitudes and understanding of ethnic groups practising consanguinity in Western society. Eur J Hum Genet. 2014; 22: 452-57.

2013

Rigter T, Henneman L, Kristoffersson U, Hall A, Yntema HG, Borry PM, Tönnies H, Waisfisz Q, Elting MW, Dondorp WJ, Cornel MC. Reflecting on earlier experiences with unsolicited findings: Points to consider for next generation sequencing and informed consent in diagnostics. Human Mutation 2013;34:1322-1328.

Henneman L, Van El CG, Cornel MC. Genetic testing and implications for personalized medicine: changes in public and healthcare professional perspectives (Editorial). Personalized Medicine 2013;10:217–219.

Wijdenes M, Henneman L, Qureshi N, Kostense PJ, Cornel MC, Timmermans DRM. Using web-based familial risk information for diabetes prevention: a randomized controlled trial. BMC Public Health 2013;13:485

Henneman L, Oosterwijk JC, Van Asperen CJ, Menko FH, Ockhuysen-Vermey CF, Kostense PJ, Claassen L, Timmermans DRM. The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trial. BMC Medical Informatics and Decision Making 2013;13:55.

Menko FH, Aalfs CM, Henneman L, Stol Y, Wijdenes M, Otten E, Ploegmakers MM, Legemaate J, Smets EM, de Wert GM, Tibben A. Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer 2013;12:319-24.

Jans SMPJ, Henneman L, de Jonge A, van El CG, van Tuyl L, Cornel MC, Lagro-Janssen ALM. "A morass of considerations": Exploring attitudes towards primary care ethnicity-based haemoglobinopathy carrier screening. Fam Pract 2013;30:604-610.

Kocken PL, Theunissen MHC, Schönbeck Y, Henneman L, Janssens ACJW, Detmar SB. Ethnicity, educational level, and attitudes contribute to parental intentions about genetic testing for child obesity. Journal of Community Genetics 2013:4;243-250.

Henneman L, Vermeulen E, El CG van, Claassen L, Timmermans DRM, Cornel MC. Public attitudes towards genetic testing revisited: comparing opinions between 2002 and 2010. Eur J Hum Genet 2013;21:793-9

2012

Borry P, Henneman L. Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility. Addiction 2012;107:2076-7.

Teeuw ME, Hagelaar A, Ten Kate LP, Cornel MC, Henneman L. Challenges in the care for consanguineous couples: an exploratory interview study among general practitioners and midwives. BMC Fam Pract 2012;13(1):105.

Kocken PL, Schönbeck Y, Henneman L, Janssens ACJW, Detmar SB. Ethnic differences and parental beliefs are important for overweight prevention and management in children: results from a cross-sectional study. BMC Public Health 2012, 12:867.

Jans SMPJ, Jonge A de, Henneman L, Cornel MC, Lagro-Janssen ALM. Attitudes of general practitioners and midwives towards ethnicity-based haemoglobinopathy carrier screening. Eur J Hum Genet 2012;20:1112-1117.

Claassen L, Henneman L, Van der Weijden T, Marteau TM, Timmermans DRM. Being at risk for cardiovascular disease: perceptions and preventive behaviour in people with and without a known predisposition. Psychol Health Med, 2012;17:511-21.

Dommering CJ, Garvelink MM, Moll AC, Van Dijk J, Imhof SM, Meijers-Heijboer H, Henneman L. Reproductive decisions of individuals with increased risk of having a child with retinoblastoma. Clin Genetics 2012;81:216-23.

Houwink EJF, Henneman L, Westerneng M, Van Luijk SJ, Cornel MC, Dinant GJ, Van der Vleuten C. Prioritisation of future genetics education for general practitioners: a Delphi study. Genet Med, 2012 14;323-329.

Janssens ACJW, Henneman L, Detmar SB, Steyerberg EW, Eijkemans MJC, Mushkudiani N, Oostra BA, Van Duijn CM, Khoury M, Mackenbach JP. Accuracy of self-reported family history is strongly influenced by the accuracy of self-reported personal health status of relatives. J Clin Epid 2012;65:82-89.

2011

Wijdenes-Pijl M, Dondorp WJ, Timmermans DRM, Cornel MC, Henneman L. Lay perceptions of predictive testing for diabetes based on DNA test results versus family history assessment: a focus group study. BMC Public Health 2011;11:535.

Claassen L, Henneman L, Nijpels G, Dekker JM, Marteau TM, Timmermans DRM. Causal beliefs and perceptions of risk for diabetes and cardiovascular disease, The Netherlands, 2007. Prevent Chronic Dis 2011;8:A130

Borry P, Henneman L, Lakeman P, Ten Kate LP, Cornel MC, Howard H. Preconceptional genetic carrier testing and the commercial offer directly-to-consumers. Human Reprod 2011;26:972-7 

Wijdenes-Pijl M, Henneman L, Cross-Bardell L, Timmermans DRM, Qureshi N. How does a simple enquiry compare to a detailed family history questionnaire to identify CHD or diabetic familial risk? Genet Med 2011;13:443-6.

Houwink EJF, Van Luijk SJ, Henneman L, Van der Vleuten C, Dinant GJ, Cornel MC. Genetic educational needs and the role of genetics in primary care: a focus group study with multiple perspectives. BMC Family Practice 2011, 12:5

Henneman L, Timmermans DRM, Bouwman CM, Cornel MC, Meijers-Heijboer H. “A low risk is still a risk”: Exploring women’s attitudes toward genetic testing for breast cancer susceptibility in order to target disease prevention. Public Health Genomics 2011;14:238-47.

2010

Teeuw ME, Henneman L, Bochdanovits Z, Heutink P, Kuik DJ, Cornel MC, Ten Kate LP. Do consanguineous parents of a child affected by an autosomal recessive disease have more DNA identical-by-descent than similarly-related parents with healthy offspring? Design of a case-control study. BMC Medical Genetics 2010;11:113.

Dommering CJ, Van den Heuvel MR, Moll AC, Imhof SM, Meijers-Heijboer H, Henneman L. Reproductive decision-making: A qualitative study among couples at increased risk of having a child with retinoblastoma. Clinical Genetics 2010;78:334-341

Claassen L, Henneman L, Janssens ACJW, Wijdenes-Pijl M, Qureshi N, Walter FM, Yoon PW, Timmermans DRM. Using family history information to promote healthy lifestyles and prevent diseases: a discussion of the evidence. BMC Public Health 2010;10:248

Ten Kate LP, Teeuw ME, Henneman L, Cornel MC. Autosomal recessive disease in children of consanguineous parents: Inferences from the proportion of compound heterozygotes. Journal of Community Genetics 2010;1:37-40.

Claassen L, Henneman L, Marteau TM, Kindt I, Timmermans DRM. Perceived risk and representations of cardiovascular disease, and preventive behavior in people diagnosed with Familial Hypercholesterolemia by DNA-testing: a cross-sectional questionnaire study. Journal of Health Psychology 2010;15 33-43

Claassen L, Henneman L, De Vet HRW, Knol D, Marteau TM, Timmermans DRM. Fatalistic responses to different types of genetic risk information; exploring the role of Self-Malleability. Psychol Health 2010; 25:183-196.

2009

Pijl M, Henneman L, Claassen L, Detmar SB, Nijpels G, Timmermans DRM. Family history of diabetes: exploring perceptions of individuals at risk in the Netherlands. Prev Chronic Dis 2009;6:A54.  

Lakeman P, Plass AMC, Henneman L, Bezemer PD, Cornel MC, Ten Kate LP. Preconceptional ancestry-based carrier couple screening for cystic fibrosis and haemoglobinopathies: what determines the intention to participate or not and actual participation. European Journal of Human Genetics 2009;17:999-1009

Pijl M, Timmermans DRM, Claassen L, Janssens AC, Nijpels G, Dekker JM, Marteau TM, Henneman L. Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioural outcomes: A randomized controlled trial. Diabetes Care 2009;32:597-9.

2008

Timmermans DRM, Ockhuysen-Vermey CF, Henneman L. Presenting health risk information in different formats: the effect on participants' cognitive and emotional evaluation and decisions. Patient Educ Couns. 2008;73:443-7. 

Lakeman P, Plass AMC, Henneman L, Bezemer PD, Cornel MC, Ten Kate LP. Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genet Med  2008;10:820-30.

Ockhuysen-Vermey CF, Henneman L, Van Asperen CJ, Oosterwijk JC, Menko FH, Timmermans DRM. Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling. BMC Cancer 2008;8:283.

Henneman L, Marteau TM, Timmermans DRM. Clinical geneticists' and genetic counselors' views on the communication of genetic risks: a qualitative study. Patient Educ Couns 2008;73:42-49.

Timmermans DRM, Henneman L, Hirasing RA, Wal van der G. Parents perceived vulnerability and perceived control in preventing Meningococcal C infection: a large-scale interview study about vaccination. BMC Public Health 2008;8:45.  

2006
Lakeman P, Henneman L, Bezemer PD, Cornel MC, Ten Kate LP. Developing and optimizing a decisional instrument using self-reported ancestry for carrier screening in a multi-ethnic society. Genet Med 2006;8:502-9.

Henneman L, Timmermans DRM, Wal van der G. Public attitudes toward genetic testing: perceived benefits and objections. Genetic Testing 2006;10:139-145. 

2005

Timmermans DRM, Henneman L, Hirasing RA, Wal van der G. Attitudes and risk perception of parents of different ethnic backgrounds regarding meningococcal C vaccination. Vaccine 2005;23: 3329-3335.

Baars MJH, Henneman L, Kate ten LP. Deficiency of knowledge of genetics and genetic tests among general practitioners, gynaecologists and paediatricians; a global problem. Genet Med, 2005;7:605-610

Baars MJH, Scherpbier AJJA, Schuwirth LW, Henneman L, Beemer FA, Cobben JM, Hennekam RCM, Verweij MMJJ, Cornel MC, Kate ten LP. Deficient knowledge of genetics relevant for daily practice among medical students nearing graduation. Genet Med 2005;7:295-301.

Weijers-Poppelaars FAM, Wildhagen MF, Henneman L, Cornel MC, Kate ten LP. Preconception cystic fibrosis carrier screening: costs and consequences. Genet Testing, 2005;9:158-66. 

2004
Baars MJH, Henneman L, Ten Kate LP. Preconceptional Cystic Fibrosis Carrier Screening: Opinions of General Practitioners, Gynecologists and Pediatricians in The Netherlands. Genet Testing 2004;8:431-436.

Henneman L, Timmermans DRM, Van der Wal G. Public Experiences, Knowledge and Expectations about Medical Genetics and the Use of Genetic Information. Community Genetics 2004;7:33-43.

Poppelaars FAM, Henneman L, Adèr HJ, Cornel MC, Hermens RPMG, Van der Wal G, Ten Kate LP. Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target population. Genet Testing 2004;8:80-89.

Poppelaars FAM, Henneman L, Ader HJ, Cornel MC, Hermens RPMG, Van der Wal G, Ten Kate LP. How should preconceptional cystic fibrosis carrier screening be provided? Opinions of potential providers and the target population. Community Genet 2003;6:157-165.(released in 2004)

Poppelaars FAM, Adèr HJ, Cornel MC, Henneman L, Hermens RPMG, Wal G van der, Ten Kate LP. Attitudes of potential providers towards preconceptional cystic fibrosis carrier screening. J Genet Counsel 2004;13:31-44. 

2003

Poppelaars FAM, Van der Wal G, Braspenning JCC, Cornel MC, Henneman L, Langendam MW, Ten Kate LP. Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group study. Public Health 2003;117:396-403.

Henneman L, Bramsen I, Van Kempen L, Van Acker MB, Pals G, Van der Horst HE, Adèr HJ, Van der Ploeg HM, Ten Kate LP. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genetics 2003;6:5-13. 

2002
Henneman L, Bramsen I, Van der Ploeg HM, Ten Kate LP. Preconception cystic fibrosis carrier couple screening: impact, understanding and satisfaction. Genetic Testing 2002;6:195-202.

Henneman L, Poppelaars FAM, Ten Kate LP. Evaluation of cystic fibrosis carrier screening programs according to genetic screening criteria. Genet Med 2002;4:241-249.

Henneman L, Kooij L, Bouman K, Ten Kate LP. Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families. Am J Med Genet 2002;110:324-331

Henneman L, Ten Kate LP. Preconceptional couple screening for cystic fibrosis carrier status: couples prefer full disclosure of test-results. J Med Genet 2002;39:e26. 

2001

Henneman L, Bramsen I, Van der Ploeg HM, Adèr HJ, Van der Horst HE, Gille JJP, Ten Kate LP. Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. J Med Genet 2001;38:695-703.

Henneman L, Bramsen I, Van Os ThAM, Reuling IEW, Heyerman HGM, Van der Laag J, Van der Ploeg HM, Ten Kate LP. Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF). Prenat Diagn 2001;21:1-9. 

<2000

Ten Kate LP, Beemer FA, Broertjes JJS, Henneman L. Community Genetics in the Netherlands. Community Genet 2000;3:131-3.

Metges CC, Petzke KJ, El-Khoury AE, Henneman L, Grant I, Bedri S, Regan MM, Fuller MF, Young VR. Incorporation of urea and ammonia nitrogen into ileal and fecal microbial proteins and plasma free amino acids in normal men and ileostomates. Am J Clin Nutr 1999;70:1046-58.

Metges CC, El-Khoury AE, Henneman L, Petzke KJ, Grant I, Bedri S, Pereira PP, Ajami AM, Fuller MF, Young VR. Availability of intestinal microbial lysine for whole body lysine homeostasis in human subjects. Am J Physiol 1999;277:E597-607.

Heemskerk JW, Feijge MA, Henneman L, Rosing J, Hemker HC. The Ca2+-mobilizing potency of alpha-thrombin and thrombin-receptor-activating peptide on human platelets concentration and time effects of thrombin-induced Ca2+ signaling. Eur J Biochem 1997;249:547-55.

- National refereed journals

Henneman L, Gitsels-van der Wal J, van der Waal L, van Rooij E, de Boer MA, Verweij EJ, Martin L, Niet-Invasieve Prenatale Test (NIPT) als eerste screeningstest? Kennis, mening en ervaringen van verloskundigen. Tijdschrift voor Verloskundigen 2015:5; 6-11.

Henneman L, Page-Christiaens GCML, Oepkes D. NIPT: uitdagingen voor de toekomst. [Non-invasive prenatal testing: challenges for future implementation]. Ned Tijdschr Geneeskd. 2015;159:A9479.

Houwink EJF, Muijtjens AMM, Jacobi FA, Henneman L, van der Vleuten C, Cornel MC, Dinant GJ. Effectiviteit van nascholing over (onco)genetica. Huisarts Wet 2014;57:294-7.

Henneman L, Bax CJ, Oepkes D, Lachmeijer AMA. Niet-invasieve prenatale testen in Nederland. Tijdschrift voor Verloskundigen. 2013; juli/aug: 34-36.

Jans SMPJ, Annegarn A, Legdeur MA, Henneman L, Lakeman P. Screenen op dragerschap van erfelijke aandoeningen tijdens het kinderwens spreekuur. Pilot project in Amsterdam. Tijdschrift voor Verloskundigen 2010;46-48.

Hesselink BAM, Henneman L, Timmermans DRM. Kiezen voor een zorgverzekering: kwalitatief onderzoek naar het keuzeproces van zorgconsumenten. Tijdschrift Gezondheidswetenschappen 2009;7:311. 

Weijers-Poppelaars FAM, Henneman L, Cornel MC, Kate ten LP. Preconceptionele screening op dragerschap voor cystische fibrose: Implementatiemogelijkheden en barrières. Huisarts en Wetenschap 2005;48:395-398.

Renders CM, Henneman L, Timmermans DRM, Hirasing RA. Televisiekijken en enkele eetgewoonten bij Amsterdamse 6-14 jarigen; een transversaal onderzoek. Nederlands Tijdschrift voor Geneeskunde 2004;42:2072-2077.

Henneman L, Poppelaars FAM, Ten Kate LP. Wenselijkheid en haalbaarheid van preconceptionele screening op dragerschap voor cystische fibrose. Nederlands Tijdschrift voor Geneeskunde. 2004;148:618-622.

Ten Kate LP, Henneman L, Poppelaars FAM. Screening op dragerschap voor cystic fibrosis in Nederland. De stand van zaken. Tijdschrift voor Gezondheidswetenschappen 2003;81:397-402.

Cornel MC, Henneman L, Ten Kate LP, Nelis AP, Van der Ploeg HM, De Smit DJ, Timmermans DRM, Van der Wal G. Onderzoek en praktijk van Community Genetics: Kennis beter delen. Tijdschrift Gezondheidswetenschappen 2002;80:542-545.

- Books, or contributions to books

Ten Kate LP, Teeuw ME, Henneman L, Cornel MC. Risk calculation in consanguinity. In: "Cousin marriages: Between tradition, genetic risk and cultural change". Edited by A Shaw and A Raz. Berghahn Books: Oxford and New York. 2015 ISBN  978-1-78238-492-2.

Henneman L, Timmermans DRM. Genetic Screening for Disease. In: James D. Wright (editor-in-chief), International Encyclopedia of the Social & Behavioral Sciences, 2nd edition, Vol 9. Oxford: Elsevier. pp. 926–931. 2015 ISBN: 9780080970868

Dommering CJ, Henneman L. Retinoblastoma and reproductive decision-making. In: M. Hayat, Editor. Tumors of the Central Nervous System, Volume 13.pp. 75-82. 2014. Springer, Netherlands. 978-94-007-7601-2.

Henneman L, Lakeman P, Ten Kate LP, Cornel MC. Status dragerschapscreening in Nederland. In: Slager E (red). Reproductieve geneeskunde, gynaecologie en obstetrie anno 2011. Haarlem: DCGH medische communicatie, 2011. ISBN 978-94-90826-07-9. pp.356-360.

Henneman L. Decision making in the context of medical genetics. In: Boerwinkel DJ, Waarlo AJ (Eds). Genomics education for decision-making. Utrecht, CD-β Press, 2010. pp. 35-42.

Henneman L, Cornel MC. Genetic carrier testing. In: Encyclopedia of life sciences. John Wiley & Sons, Ltd: Chichester. 2009. http://www.els.net/ .

Timmermans DRM, Henneman L. Genetic testing. In: Kattan MW, ed. Encyclopedia of Medical Decision Making. Thousand Oaks, CA: Sage Publications, 2009. 

Henneman L. Kiezen voor mannen en/of vrouwen. In: MC Cornel, L Henneman, AMA Lachmeijer (eds.). Gaat heen en vermenigvuldigt u. Liber amicorum voor LP ten Kate. 2005. ISBN 90-90132-1.

Detmar S, Henneman L. Genomics. In: Bonnet-Breusers AJM, Hirasing RA, Hoppenbrouwers K, Rensen HBH, Wagenaar-Fischer MM (eds.) Praktijkboek Jeugdgezondheidszorg. Maarssen: Elsevier Gezondheidszorg, 2005. I 1.22-1-10. ISBN 9035222571.

Henneman L, Welkenhuysen M. Genetic Carrier Testing. In: Cooper DN (ed.) Nature Encyclopedia of the Human Genome, vol. 2, pp. 731-734. London: Nature Publishing Group, 2003.

Broertjes JJS, Henneman L, Beemer FA (eds). Community genetics: Past and future. Department of Biological Education. Utrecht University. Utrecht, 2002. ISBN 90-393-3245-2.

Henneman L, Bramsen I, Gille JJP, Van der Ploeg HM, Ten Kate LP. Preconceptional cystic fibrosis carrier couple screening: impact, understanding and satisfaction. In: Broertjes JJS, Henneman L, Beemer FA (eds). Community genetics: Past and future. Department of Biological Education. Utrecht University. Utrecht, 2002. pp. 61-64. ISBN 90-393-3245-2.

Henneman L (2002) Preconceptional cystic fibrosis carrier screening-- Desirability and feasibility in the Netherlands. VU University, Amsterdam.[thesis] ISBN 90-5669-061-2. 

- Conference reports

Dekkers C, Henneman L, Limburg W, Van Poppel M. Verslag van het Nederlands Public Health Congres 2003. Tijdschrift voor Gezondheidswetenschappen 2003;81:373.

Henneman L. Wetenschappelijke dag Community genetics. Tijdschrift voor Gezondheidswetenschappen 2003;81: 57-58.

Henneman L, Langendam MW, Ten Kate LP. Community Genetics and its evaluation: a European Science Foundation workshop. Community Genetics 2001;4:56-9.

- Other publications

Bolhuis PA, Henneman L. Screening bij kinderwens komt eraan. Medisch Contact 2014;39:1884-6.

Timmermans DRM, Henneman L. The communication of genetic risks: What we know and what we need to learn. Essay for the programme “Societal Component of Genomics”, NWO and Netherlands Genomics Initiative, The Hague, 2002.

Timmermans DRM, Henneman L. Risk perception and informed decision making in genetic contexts. Essay for the programme “Societal Component of Genomics”, NWO and Netherlands Genomics Initiative, The Hague, 2002.

Henneman L. Cystic Fibrosis in Nederland. Resultaten van een landelijk onderzoek in 1997. Onderzoeksrapport Vrije Universiteit Amsterdam, 1999.

Henneman L. Community genetics: wat, waarom en hoe! In Dienst der Genezing. 1999;28(4):4-6.